Cargando…
Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
The vast majority of cancer-related deaths are due to metastasis, a process that requires evasion of the host immune system. In addition, a significant percentage of cancer patients do not benefit from our current immunotherapy arsenal due to either primary or secondary immunotherapy resistance. Imp...
Autores principales: | DeVito, Nicholas C., Plebanek, Michael P., Theivanthiran, Bala, Hanks, Brent A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914818/ https://www.ncbi.nlm.nih.gov/pubmed/31921140 http://dx.doi.org/10.3389/fimmu.2019.02876 |
Ejemplares similares
-
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis
por: Theivanthiran, Balamayooran, et al.
Publicado: (2021) -
Editorial: Signaling pathways behind immune evasion and therapy resistance
por: Martin-Orozco, Elena, et al.
Publicado: (2022) -
Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse Events
por: Oswalt, Cameron J., et al.
Publicado: (2022) -
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
por: Chen, Chen, et al.
Publicado: (2023) -
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy
por: DeVito, Nicholas C., et al.
Publicado: (2021)